Gurcınar, I. H. Et Al. 2023. Combined IL6R inhibition and immunotherapy as a novel neoadjuvant therapeutic approach in murine pancreatic cancer: a preclinical study protocol. 55th EPC Meeting , (Innsbruck, Austria), 117-118.

Gurcınar, I. H., Safak, O., Tokalov, S., Frıess, H., Ceyhan, G. O., Istvanffy, R., ... Demır, E.(2023). Combined IL6R inhibition and immunotherapy as a novel neoadjuvant therapeutic approach in murine pancreatic cancer: a preclinical study protocol . 55th EPC Meeting (pp.117-118). Innsbruck, Austria

Gurcınar, Ibrahım Et Al. "Combined IL6R inhibition and immunotherapy as a novel neoadjuvant therapeutic approach in murine pancreatic cancer: a preclinical study protocol," 55th EPC Meeting, Innsbruck, Austria, 2023

Gurcınar, Ibrahım H. Et Al. "Combined IL6R inhibition and immunotherapy as a novel neoadjuvant therapeutic approach in murine pancreatic cancer: a preclinical study protocol." 55th EPC Meeting , Innsbruck, Austria, pp.117-118, 2023

Gurcınar, I. H. Et Al. (2023) . "Combined IL6R inhibition and immunotherapy as a novel neoadjuvant therapeutic approach in murine pancreatic cancer: a preclinical study protocol." 55th EPC Meeting , Innsbruck, Austria, pp.117-118.

@conferencepaper{conferencepaper, author={Ibrahım Halıl Gurcınar Et Al. }, title={Combined IL6R inhibition and immunotherapy as a novel neoadjuvant therapeutic approach in murine pancreatic cancer: a preclinical study protocol}, congress name={55th EPC Meeting}, city={Innsbruck}, country={Austria}, year={2023}, pages={117-118} }